ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 198 filers reported holding ROYALTY PHARMA PLC in Q4 2020. The put-call ratio across all filers is 2.07 and the average weighting 1.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,035,556 | +0.9% | 185,540 | +14.2% | 0.01% | 0.0% |
| Q2 2023 | $4,993,098 | +16.2% | 162,430 | +36.1% | 0.01% | 0.0% |
| Q1 2023 | $4,298,811 | +1.8% | 119,312 | +11.3% | 0.01% | -16.7% |
| Q4 2022 | $4,223,050 | +6.8% | 107,184 | +8.9% | 0.01% | -7.7% |
| Q3 2022 | $3,953,000 | +4.1% | 98,384 | +9.0% | 0.01% | -23.5% |
| Q2 2022 | $3,796,000 | +19.4% | 90,284 | +10.7% | 0.02% | +30.8% |
| Q1 2022 | $3,179,000 | -2.6% | 81,584 | -1.7% | 0.01% | 0.0% |
| Q4 2021 | $3,263,000 | +104.1% | 83,036 | +87.7% | 0.01% | +62.5% |
| Q3 2021 | $1,599,000 | +7.4% | 44,236 | +21.7% | 0.01% | 0.0% |
| Q2 2021 | $1,489,000 | -6.8% | 36,336 | -0.8% | 0.01% | -20.0% |
| Q1 2021 | $1,597,000 | +47.3% | 36,613 | +69.0% | 0.01% | +25.0% |
| Q4 2020 | $1,084,000 | – | 21,664 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Siguler Guff Advisers, LLC | 3,391,754 | $92,052,204 | 47.04% |
| Indie Asset Partners, LLC | 433,000 | $11,751,620 | 11.84% |
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4,095,745 | $111,158,519 | 6.01% |
| Advanced Portfolio Management, LLC | 230,000 | $6,242,200 | 5.25% |
| Compound Global Advisors, LLC | 626,412 | $17,000,822 | 3.73% |
| Geo Capital Gestora de Recursos Ltd | 135,079 | $3,666 | 3.39% |
| TORRAY INVESTMENT PARTNERS LLC | 412,633 | $11,198,860 | 1.98% |
| Overbrook Management Corp | 298,712 | $8,107,044 | 1.89% |
| Silicon Valley Community Foundation | 358,270 | $9,723,448 | 1.18% |
| Greytown Advisors Inc. | 74,601 | $2,024,671 | 1.12% |